Abbvie Inc (NYSE:ABBV)

135.85
Delayed Data
As of Jan 14
 +2.33 / +1.75%
Today’s Change
101.81
Today|||52-Week Range
138.15
+0.33%
Year-to-Date
Pfizer's (PFE) Cibinqo Gets FDA Nod for Atopic Dermatitis
9:20am / Zacks.com - Paid Partner Content
Pfizer (PFE) Partners Beam Therapeutics for Rare Disease Drugs
Jan 11 / Zacks.com - Paid Partner Content
4 Large-Cap Drugmaker Stocks to Watch Despite Omicron Woes
8:25am / Zacks.com - Paid Partner Content
AbbVie (ABBV) Gains As Market Dips: What You Should Know
Jan 10 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer (PFE), Beam Therapeutics, AbbVie, Merck and Glaxo
8:16am / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Inks Deal to Develop ATTR-CM Candidate
Jan 10 / Zacks.com - Paid Partner Content
Is AbbVie a Good Dividend Stock to Buy Right Now?
6:07am / MotleyFool.com - Paid Partner Content
Sanofi (SNY) Inks Deal to Develop AI-Driven Precision Medicines
Jan 10 / Zacks.com - Paid Partner Content
3 Pharma Stocks With Especially Juicy Dividends
Jan 16 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer, AbbVie, Eli Lilly and J&J
Jan 10 / Zacks.com - Paid Partner Content
Sara-Bay Financial Buys Cerence Inc, Public Service Enterprise Group Inc, Welltower Inc, Sells ...
Jan 14 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) Seeks Rinvoq Nod for Non-Radiographic AS
Jan 10 / Zacks.com - Paid Partner Content
FourThought Financial, LLC Buys Northrop Grumman Corp, Lockheed Martin Corp, Xcel Energy Inc, ...
Jan 14 / GuruFocus News - Paid Partner Content
3 No-Brainer Big Pharma Stocks to Buy in 2022
Jan 09 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: PFE's Research Deal With BEAM & Other Updates
Jan 14 / Zacks.com - Paid Partner Content
Aligos (ALGS) Stock Down on Hepatitis Drug Development Halt
Jan 07 / Zacks.com - Paid Partner Content
Northern Capital Management, Inc. Buys McDonald's Corp, Duke Energy Corp, AbbVie Inc
Jan 13 / GuruFocus News - Paid Partner Content
Lilly (LLY) Inks Deal for Multiple Neurologic Indications
Jan 07 / Zacks.com - Paid Partner Content
Veery Capital, LLC Buys Schwab U.S. Small-Cap ETF, Schwab International Equity ETF, Schwab U.S. ...
Jan 13 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: FDA Nod to PFE Booster for Age 12-15, Breakthrough Tag to ABBV Drug
Jan 07 / Zacks.com - Paid Partner Content
Murphy, Middleton, Hinkle & Parker, Inc. Buys Aflac Inc, Schwab U.S. REIT ETF, AbbVie Inc
Jan 13 / GuruFocus News - Paid Partner Content
Zacks Investment Ideas feature highlights: AbbVie, Inc. and Pfizer Inc
Jan 07 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds
Jan 13 / Zacks.com - Paid Partner Content
How to Select Stocks During Volatile Market Periods
Jan 06 / Zacks.com - Paid Partner Content
4 Top Dividend Payers of the S&P 500
Jan 13 / MotleyFool.com - Paid Partner Content
4 Reasons Why You Should Add AbbVie (ABBV) to Your Portfolio
Jan 06 / Zacks.com - Paid Partner Content
Does Johnson & Johnson's Split Make Sense?
Jan 12 / MotleyFool.com - Paid Partner Content
Top Analyst Reports for JPMorgan, Toyota & Netflix
Jan 05 / Zacks.com - Paid Partner Content
Kmg Fiduciary Partners, Llc Buys NVIDIA Corp, PayPal Holdings Inc, Delta Air Lines Inc, Sells ...
Jan 12 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) is an Incredible Growth Stock: 3 Reasons Why
Jan 05 / Zacks.com - Paid Partner Content
The 3 Best S&P 500 High Yield Dividend Stocks For 2022
Jan 12 / StockNews.com - Paid Partner Content
AbbVie (ABBV) Gets FDA Breakthrough Tag for Lung Cancer Drug
Jan 05 / Zacks.com - Paid Partner Content
2 Monster Stocks to Buy for 2022 That Are Practically Minting Money
Jan 12 / MotleyFool.com - Paid Partner Content
Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?
Jan 04 / Zacks.com - Paid Partner Content
Centre Asset Management, LLC Buys BHP Group, Intel Corp, Coterra Energy Inc, Sells Meta ...
Jan 11 / GuruFocus News - Paid Partner Content
This Big Pharma Stock Is Enriching Shareholders With Its Dividend. But Is It a Buy?
Jan 04 / MotleyFool.com - Paid Partner Content
Merck (MRK) Keytruda Betters Survival in Adjuvant Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content